CroatiaOther
Procurement of ocrelizumab medicine
The procurement covers ocrelizumab medicine for treatment needs in healthcare. The estimated contract value is about EUR 374,992.
- Estimated value
- €374,992
- Published
- 17 Jun 2026
- CPV
- 33690000
Get help from a local consultant
Bidding cross-border? A Baltmodus consultant who works in this market can help you prepare and submit.
Find a consultant